<DOC>
	<DOCNO>NCT02587364</DOCNO>
	<brief_summary>The purpose study evaluate multiple‐dose pharmacokinetic characteristic pharmacologic activity gemcabene .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics Study Gemcabene Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Good health determine medical history , physical examination , electrocardiogram ( ECG ) , vital sign , laboratory assessment Body weight : 60‐100 kg ( desirable ) Use medication consider acceptable clinical investigator 14‐day period start study ( Day 1 ) ; Donation unit blood participation study investigational market drug 30‐day period start study ( Day 1 ) ; If female , childbearing potential lactating ; History significant reaction fibrate lipid‐lowering agent ; Significant urine collection drug could interfere study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Lipid Regulator</keyword>
</DOC>